Symbols / ATEC Stock $7.66 +1.19% Alphatec Holdings, Inc.

Healthcare • Medical Devices • United States • NMS
ATEC (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Patrick S. Miles
Exch · Country NMS · United States
Market Cap 1.18B
Enterprise Value 1.66B
Income -125.36M
Sales 787.08M
FCF (ttm) 54.57M
Book/sh -0.04
Cash/sh 0.91
Employees 913
Insider 10d —
IPO Jun 12, 2006
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 13.30
PEG 0.48
P/S 1.50
P/B -218.86
P/C —
EV/EBITDA 58.61
EV/Sales 2.12
Quick Ratio 1.05
Current Ratio 1.90
Debt/Eq 3,303.35
LT Debt/Eq —
EPS (ttm) -0.83
EPS next Y 0.58
EPS Growth —
Revenue Growth 13.60%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-07-30
Earnings (prior) 2026-05-05
ROA -3.81%
ROE —
ROIC —
Gross Margin 70.18%
Oper. Margin -11.48%
Profit Margin -15.93%
Shs Outstand 153.79M
Shs Float 121.45M
Insider Own 20.35%
Instit Own 76.88%
Short Float 8.95%
Short Ratio 4.63
Short Interest 11.92M
52W High 23.29
vs 52W High -67.11%
52W Low 6.82
vs 52W Low 12.32%
Beta 0.97
Impl. Vol. 66.11%
Rel Volume 0.88
Avg Volume 3.28M
Volume 2.88M
Target (mean) $17.33
Tgt Median $16.00
Tgt Low $11.00
Tgt High $24.00
# Analysts 12
Recom Strong_buy
Prev Close $7.57
Price $7.66
Change 1.19%
About

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$17.33
Mean price target
2. Current target
$7.66
Latest analyst target
3. DCF / Fair value
$6.39
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$7.66
Low
$11.00
High
$24.00
Mean
$17.33

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-07 main Barclays Overweight → Overweight $24
2026-05-07 main Wells Fargo Overweight → Overweight $14
2026-05-07 reit HC Wainwright & Co. Buy → Buy $24
2026-05-06 main Canaccord Genuity Buy → Buy $23
2026-05-06 main JP Morgan Overweight → Overweight $16
2026-05-06 main TD Cowen Buy → Buy $11
2026-05-06 reit Piper Sandler Overweight → Overweight $14
2026-05-06 main Needham Buy → Buy $14
2026-03-09 main Stifel Buy → Buy $20
2026-01-12 reit Needham Buy → Buy $22
2026-01-12 reit HC Wainwright & Co. Buy → Buy $24
2026-01-07 main Barclays Overweight → Overweight $27
2025-12-11 init Freedom Capital Markets — → Buy $25
2025-11-10 main Morgan Stanley Equal-Weight → Equal-Weight $21
2025-11-03 main Barclays Overweight → Overweight $23
2025-10-31 main Canaccord Genuity Buy → Buy $25
2025-10-31 reit Piper Sandler Overweight → Overweight $25
2025-10-31 main Stifel Buy → Buy $24
2025-10-31 main HC Wainwright & Co. Buy → Buy $24
2025-10-31 main Needham Buy → Buy $22
News
RSS: Latest ATEC news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-11 VALENTINE KEITH C Director — 135,000 $7.00 $996,192
2026-04-07 MARSHALL TYSON ELIOT General Counsel — 102,500 $1.68 $258,050
2026-03-13 KONING JOHN TODD Chief Financial Officer — 79,789 $12.36 $986,192
2026-03-13 LISH SCOTT Chief Operating Officer — 260,535 $12.30 $3,204,580
2026-03-11 SPONSEL DAVID Officer — 163,452 $12.52 $2,046,419
2026-03-09 HUNSAKER CRAIG E Officer — 600 $0.00 $0
2026-03-09 HUNSAKER CRAIG E Officer — 116,367 $12.22 $1,441,041
2026-03-05 MARSHALL TYSON ELIOT General Counsel — 88,835 $12.49 $1,109,549
2026-02-25 MARSHALL TYSON ELIOT General Counsel — 302,852 $0.00 $0
2026-02-25 SPONSEL DAVID Officer — 318,884 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
764.15
+24.95%
611.56
+26.81%
482.26
+37.45%
350.87
Operating Revenue
764.15
+24.95%
611.56
+26.81%
482.26
+37.45%
350.87
Cost Of Revenue
232.27
+24.01%
187.30
+8.86%
172.06
+46.05%
117.81
Reconciled Cost Of Revenue
164.76
+37.03%
120.24
-5.07%
126.66
+50.80%
84.00
Gross Profit
531.89
+25.37%
424.26
+36.77%
310.20
+33.10%
233.06
Operating Expense
589.85
+7.80%
547.17
+19.35%
458.48
+29.45%
354.16
Research And Development
76.27
-5.51%
80.72
+15.12%
70.11
+59.23%
44.03
Selling General And Administration
498.53
+10.73%
450.20
+20.35%
374.08
+24.69%
300.01
Total Expenses
822.12
+11.93%
734.48
+16.48%
630.54
+33.60%
471.97
Operating Income
-57.97
+52.84%
-122.91
+17.11%
-148.28
-22.44%
-121.10
Total Operating Income As Reported
-82.13
+39.69%
-136.17
+21.47%
-173.40
-17.98%
-146.97
EBITDA
-14.92
+72.31%
-53.87
+51.29%
-110.59
-7.81%
-102.58
Normalized EBITDA
26.20
+164.50%
-40.62
+52.48%
-85.47
-11.43%
-76.70
Reconciled Depreciation
82.56
-0.91%
83.32
+39.61%
59.68
+35.86%
43.93
EBIT
-97.48
+28.95%
-137.19
+19.43%
-170.27
-16.22%
-146.50
Total Unusual Items
-41.12
-210.18%
-13.26
+47.23%
-25.12
+2.91%
-25.87
Total Unusual Items Excluding Goodwill
-41.12
-210.18%
-13.26
+47.23%
-25.12
+2.91%
-25.87
Special Income Charges
-41.74
-214.86%
-13.26
+47.23%
-25.12
+2.91%
-25.87
Other Special Charges
41.36
+322.08%
9.80
-56.03%
22.29
-6.92%
23.94
Restructuring And Mergern Acquisition
0.38
-89.07%
3.46
+22.07%
2.83
+46.74%
1.93
Net Income
-143.36
+11.57%
-162.12
+13.14%
-186.64
-23.36%
-151.29
Pretax Income
-143.40
+11.52%
-162.07
+13.29%
-186.91
-22.96%
-152.01
Net Non Operating Interest Income Expense
-45.92
-84.58%
-24.88
-49.50%
-16.64
-202.29%
-5.50
Interest Expense Non Operating
45.92
+84.58%
24.88
+49.50%
16.64
+202.29%
5.50
Net Interest Income
-45.92
-84.58%
-24.88
-49.50%
-16.64
-202.29%
-5.50
Interest Expense
45.92
+84.58%
24.88
+49.50%
16.64
+202.29%
5.50
Other Income Expense
-39.52
-176.70%
-14.28
+35.08%
-22.00
+13.40%
-25.40
Other Non Operating Income Expenses
1.60
+256.39%
-1.02
-132.84%
3.12
+562.63%
0.47
Gain On Sale Of Security
0.62
—
—
—
Tax Provision
-0.04
-190.00%
0.05
+118.05%
-0.28
+61.31%
-0.72
Tax Rate For Calcs
0.00
-99.85%
0.00
+12252.94%
0.00
-63.83%
0.00
Tax Effect Of Unusual Items
-0.01
+99.54%
-2.78
-6418.99%
-0.04
+64.88%
-0.12
Net Income Including Noncontrolling Interests
-143.36
+11.57%
-162.12
+13.14%
-186.64
-23.36%
-151.29
Net Income From Continuing Operation Net Minority Interest
-143.36
+11.57%
-162.12
+13.14%
-186.64
-23.36%
-151.29
Net Income From Continuing And Discontinued Operation
-143.36
+11.57%
-162.12
+13.14%
-186.64
-23.36%
-151.29
Net Income Continuous Operations
-143.36
+11.57%
-162.12
+13.14%
-186.64
-23.36%
-151.29
Normalized Income
-102.25
+32.57%
-151.65
+6.13%
-161.56
-28.69%
-125.54
Net Income Common Stockholders
-143.36
+11.57%
-162.12
+13.14%
-186.64
-23.36%
-151.29
Diluted EPS
-0.96
+15.04%
-1.13
+26.62%
-1.54
-4.76%
-1.47
Basic EPS
-0.96
+15.04%
-1.13
+26.62%
-1.54
-4.76%
-1.47
Basic Average Shares
150.06
+4.98%
142.95
+17.90%
121.24
+17.29%
103.37
Diluted Average Shares
150.06
+4.98%
142.95
+17.90%
121.24
+17.29%
103.37
Diluted NI Availto Com Stockholders
-143.36
+11.57%
-162.12
+13.14%
-186.64
-23.36%
-151.29
Amortization
15.06
-7.37%
16.26
+13.82%
14.28
+41.22%
10.12
Amortization Of Intangibles Income Statement
15.06
-7.37%
16.26
+13.82%
14.28
+41.22%
10.12
Depreciation Amortization Depletion Income Statement
15.06
-7.37%
16.26
+13.82%
14.28
+41.22%
10.12
Depreciation And Amortization In Income Statement
15.06
-7.37%
16.26
+13.82%
14.28
+41.22%
10.12
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
791.21
+2.00%
775.71
-3.66%
805.21
+54.56%
520.97
Current Assets
450.88
+8.02%
417.40
-7.47%
451.09
+76.46%
255.63
Cash Cash Equivalents And Short Term Investments
160.81
+15.82%
138.84
-37.17%
220.97
+160.90%
84.70
Cash And Cash Equivalents
160.81
+15.82%
138.84
-37.17%
220.97
+160.90%
84.70
Receivables
97.30
+17.25%
82.99
+14.29%
72.61
+20.90%
60.06
Accounts Receivable
97.30
+17.25%
82.99
+14.29%
72.61
+20.90%
60.06
Gross Accounts Receivable
109.99
+25.34%
87.75
+19.35%
73.52
+21.05%
60.74
Allowance For Doubtful Accounts Receivable
-12.69
-166.32%
-4.76
-423.41%
-0.91
-34.02%
-0.68
Inventory
169.44
-3.32%
175.26
+28.08%
136.84
+34.79%
101.52
Raw Materials
11.96
-38.29%
19.38
-17.17%
23.39
+67.96%
13.93
Work In Process
—
0.00
-100.00%
0.95
-68.67%
3.03
Finished Goods
157.49
+1.03%
155.89
+38.57%
112.50
+33.04%
84.56
Prepaid Assets
—
—
—
—
Other Current Assets
23.32
+14.84%
20.31
-1.73%
20.67
+120.86%
9.36
Total Non Current Assets
340.33
-5.02%
358.31
+1.18%
354.12
+33.46%
265.33
Net PPE
166.55
-12.84%
191.09
+8.43%
176.25
+35.25%
130.31
Gross PPE
399.89
+6.72%
374.71
+23.62%
303.12
+34.96%
224.61
Accumulated Depreciation
-233.35
-27.08%
-183.62
-44.72%
-126.88
-34.55%
-94.29
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
52.10
+1.07%
51.55
+118.10%
23.64
+24.30%
19.02
Construction In Progress
0.65
+19.41%
0.54
-97.81%
24.73
+61.02%
15.36
Other Properties
342.74
+7.68%
318.30
+26.93%
250.77
+33.91%
187.27
Leases
4.40
+1.87%
4.32
+8.40%
3.99
+34.44%
2.96
Goodwill And Other Intangible Assets
168.66
+2.53%
164.49
-6.25%
175.45
+34.81%
130.15
Goodwill
75.21
+5.96%
70.98
-2.78%
73.00
+54.12%
47.37
Other Intangible Assets
93.45
-0.07%
93.52
-8.72%
102.45
+23.76%
82.78
Other Non Current Assets
5.12
+88.13%
2.72
+12.57%
2.42
-50.39%
4.87
Total Liabilities Net Minority Interest
778.78
-1.40%
789.88
+8.64%
727.09
+30.86%
555.63
Current Liabilities
219.18
+43.23%
153.03
-2.89%
157.57
+13.47%
138.87
Payables And Accrued Expenses
131.97
+1.41%
130.13
+1.13%
128.67
+26.79%
101.49
Payables
42.55
-23.31%
55.49
+8.87%
50.97
+38.89%
36.70
Accounts Payable
40.89
-22.82%
52.98
+8.16%
48.98
+41.00%
34.74
Current Accrued Expenses
89.42
+19.79%
74.64
-3.94%
77.70
+19.93%
64.79
Employee Benefits
0.86
+28.10%
0.67
—
—
Total Tax Payable
1.66
-33.69%
2.50
+26.20%
1.99
+1.53%
1.96
Current Debt And Capital Lease Obligation
70.82
+773.40%
8.11
+16.39%
6.97
-64.80%
19.79
Current Debt
64.53
+3796.50%
1.66
-8.41%
1.81
-87.90%
14.95
Other Current Borrowings
64.53
+3796.50%
1.66
-8.41%
1.81
-87.90%
14.95
Current Capital Lease Obligation
6.30
-2.40%
6.45
+25.08%
5.16
+6.55%
4.84
Current Deferred Liabilities
10.44
-0.27%
10.47
-24.75%
13.91
+16.34%
11.96
Current Deferred Revenue
10.44
-0.27%
10.47
-24.75%
13.91
+16.34%
11.96
Other Current Liabilities
5.94
+37.60%
4.32
-46.20%
8.02
+42.32%
5.64
Total Non Current Liabilities Net Minority Interest
559.61
-12.13%
636.85
+11.82%
569.52
+36.65%
416.76
Long Term Debt And Capital Lease Obligation
525.27
-12.72%
601.83
+12.55%
534.71
+42.18%
376.07
Long Term Debt
501.41
-12.73%
574.52
+12.42%
511.04
+46.21%
349.51
Long Term Capital Lease Obligation
23.86
-12.63%
27.30
+15.32%
23.68
-10.86%
26.56
Tradeand Other Payables Non Current
4.58
-9.75%
5.08
-13.04%
5.84
-10.54%
6.53
Non Current Deferred Liabilities
2.18
-30.37%
3.13
+22.26%
2.56
-15.95%
3.05
Non Current Deferred Revenue
2.18
-30.37%
3.13
+22.26%
2.56
-15.95%
3.05
Other Non Current Liabilities
3.12
+22.43%
2.55
-9.20%
2.80
-62.69%
7.52
Preferred Securities Outside Stock Equity
23.60
+0.00%
23.60
+0.00%
23.60
+0.00%
23.60
Stockholders Equity
12.43
+187.69%
-14.17
-118.14%
78.12
+325.33%
-34.67
Common Stock Equity
12.43
+187.69%
-14.17
-118.14%
78.12
+325.33%
-34.67
Capital Stock
0.01
+0.00%
0.01
+0.00%
0.01
+27.27%
0.01
Common Stock
0.01
+0.00%
0.01
+0.00%
0.01
+27.27%
0.01
Preferred Stock
—
—
0.00
0.00
Share Issued
150.26
+2.96%
145.94
+3.46%
141.05
+30.07%
108.45
Ordinary Shares Number
148.45
+3.00%
144.13
+3.51%
139.25
+30.58%
106.64
Treasury Shares Number
1.81
+0.00%
1.81
+0.00%
1.81
+0.00%
1.81
Additional Paid In Capital
1,466.38
+12.31%
1,305.68
+6.11%
1,230.48
+31.81%
933.54
Retained Earnings
-1,424.44
-11.19%
-1,281.09
-14.49%
-1,118.96
-20.02%
-932.32
Gains Losses Not Affecting Retained Earnings
-4.43
+67.64%
-13.68
-64.34%
-8.32
+22.89%
-10.79
Treasury Stock
25.10
+0.00%
25.10
+0.00%
25.10
+0.00%
25.10
Other Equity Adjustments
-4.43
+67.64%
-13.68
-64.34%
-8.32
+22.89%
-10.79
Total Equity Gross Minority Interest
12.43
+187.70%
-14.17
-118.14%
78.12
+325.33%
-34.67
Total Capitalization
513.84
-8.30%
560.35
-4.89%
589.15
+87.12%
314.84
Working Capital
231.70
-12.36%
264.37
-9.93%
293.52
+151.38%
116.76
Invested Capital
578.36
+2.91%
562.01
-4.90%
590.96
+79.19%
329.79
Total Debt
596.09
-2.27%
609.94
+12.60%
541.68
+36.83%
395.86
Net Debt
405.13
-7.36%
437.34
+49.84%
291.87
+4.33%
279.76
Capital Lease Obligations
30.15
-10.68%
33.76
+17.07%
28.84
-8.18%
31.40
Net Tangible Assets
-156.24
+12.55%
-178.66
-83.55%
-97.34
+40.94%
-164.81
Tangible Book Value
-156.24
+12.55%
-178.66
-83.55%
-97.34
+40.94%
-164.81
Interest Payable
1.81
+28.82%
1.40
-20.02%
1.75
+56.24%
1.12
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
45.23
+201.30%
-44.65
+43.11%
-78.48
-4.46%
-75.13
Cash Flow From Continuing Operating Activities
45.23
+201.30%
-44.65
+43.11%
-78.48
-4.46%
-75.13
Net Income From Continuing Operations
-143.36
+11.57%
-162.12
+13.14%
-186.64
-23.36%
-151.29
Depreciation Amortization Depletion
82.56
-0.91%
83.32
+39.61%
59.68
+35.86%
43.93
Depreciation
82.56
-0.91%
83.32
+39.61%
59.68
+35.86%
43.93
Depreciation And Amortization
82.56
-0.91%
83.32
+39.61%
59.68
+35.86%
43.93
Other Non Cash Items
30.90
+220.01%
9.66
+136.15%
4.09
+26.79%
3.23
Stock Based Compensation
73.72
+0.60%
73.28
-9.81%
81.24
+100.33%
40.56
Provisionand Write Offof Assets
—
—
—
—
Asset Impairment Charge
13.54
-12.23%
15.42
+13.32%
13.61
+38.97%
9.79
Operating Gains Losses
19.43
+532.42%
3.07
-17.15%
3.71
+42.95%
2.59
Gain Loss On Investment Securities
-0.62
—
—
—
Change In Working Capital
-31.56
+53.09%
-67.27
-24.17%
-54.18
-126.35%
-23.94
Change In Receivables
-21.88
-49.97%
-14.59
-14.02%
-12.79
+32.06%
-18.83
Changes In Account Receivables
-21.88
-49.97%
-14.59
-14.02%
-12.79
+32.06%
-18.83
Change In Inventory
-6.31
+88.45%
-54.66
-19.97%
-45.56
-120.06%
-20.70
Change In Prepaid Assets
-1.75
-1709.28%
-0.10
+99.13%
-11.10
-2110.51%
0.55
Change In Payables And Accrued Expense
4.67
-40.84%
7.89
-67.11%
23.99
+2.94%
23.30
Change In Accrued Expense
15.82
+988.49%
-1.78
-110.48%
17.00
+25.85%
13.51
Change In Payable
-11.16
-215.36%
9.67
+38.37%
6.99
-28.65%
9.80
Change In Account Payable
-11.16
-215.36%
9.67
+38.37%
6.99
-28.65%
9.80
Change In Other Working Capital
-0.27
+91.69%
-3.26
-281.87%
1.79
+178.64%
-2.28
Change In Other Current Assets
0.41
+186.91%
-0.47
+13.86%
-0.54
-396.33%
-0.11
Change In Other Current Liabilities
-6.41
-206.60%
-2.09
+79.01%
-9.96
-69.83%
-5.87
Investing Cash Flow
-53.41
+42.65%
-93.14
+34.40%
-141.97
-143.61%
-58.28
Cash Flow From Continuing Investing Activities
-53.41
+42.65%
-93.14
+34.40%
-141.97
-143.61%
-58.28
Net PPE Purchase And Sale
-42.45
+48.99%
-83.22
-3.37%
-80.51
-62.80%
-49.45
Purchase Of PPE
-42.45
+48.99%
-83.22
-3.37%
-80.51
-62.80%
-49.45
Sale Of PPE
—
—
—
—
Capital Expenditure
-49.64
+46.70%
-93.14
-7.08%
-86.97
-49.24%
-58.28
Net Investment Purchase And Sale
-3.00
0.00
0.00
0.00
Purchase Of Investment
-3.00
0.00
0.00
0.00
Net Business Purchase And Sale
0.00
0.00
+100.00%
-55.00
0.00
Purchase Of Business
0.00
0.00
+100.00%
-55.00
0.00
Net Intangibles Purchase And Sale
-7.19
+27.51%
-9.91
-53.29%
-6.47
+26.74%
-8.83
Purchase Of Intangibles
-7.19
+27.51%
-9.91
-53.29%
-6.47
+26.74%
-8.83
Net Other Investing Changes
-0.77
—
—
—
Financing Cash Flow
30.02
-46.59%
56.21
-84.25%
356.92
+1042.95%
31.23
Cash Flow From Continuing Financing Activities
30.02
-46.59%
56.21
-84.25%
356.92
+1042.95%
31.23
Net Issuance Payments Of Debt
74.81
+27.23%
58.80
-60.71%
149.66
+327.59%
35.00
Issuance Of Debt
407.00
+82.53%
222.97
-21.06%
282.47
+351.96%
62.50
Repayment Of Debt
-332.19
-102.34%
-164.18
-23.61%
-132.81
-382.96%
-27.50
Long Term Debt Issuance
407.00
+82.53%
222.97
-21.06%
282.47
+351.96%
62.50
Long Term Debt Payments
-332.19
-102.34%
-164.18
-23.61%
-132.81
-382.96%
-27.50
Net Long Term Debt Issuance
74.81
+27.23%
58.80
-60.71%
149.66
+327.59%
35.00
Short Term Debt Issuance
—
—
134.00
+114.40%
62.50
Short Term Debt Payments
—
—
-119.50
-334.55%
-27.50
Net Short Term Debt Issuance
—
—
134.00
+114.40%
62.50
Net Common Stock Issuance
0.00
0.00
-100.00%
213.18
0.00
Common Stock Payments
—
—
-1.06
+65.01%
-3.04
Repurchase Of Capital Stock
—
—
-1.06
+65.01%
-3.04
Proceeds From Stock Option Exercised
0.52
+191.96%
-0.56
+47.37%
-1.06
+65.01%
-3.04
Net Other Financing Charges
-45.31
-2129.82%
-2.03
+58.15%
-4.86
-564.30%
-0.73
Changes In Cash
21.84
+126.77%
-81.58
-159.78%
136.46
+233.54%
-102.19
Effect Of Exchange Rate Changes
0.13
+123.23%
-0.55
-197.84%
-0.18
+49.45%
-0.37
Beginning Cash Position
138.84
-37.17%
220.97
+160.90%
84.70
-54.77%
187.25
End Cash Position
160.81
+15.82%
138.84
-37.17%
220.97
+160.90%
84.70
Free Cash Flow
-4.41
+96.80%
-137.79
+16.72%
-165.46
-24.02%
-133.41
Interest Paid Supplemental Data
23.82
+17.25%
20.32
+17.64%
17.27
+347.38%
3.86
Income Tax Paid Supplemental Data
0.39
+41.45%
0.28
-17.42%
0.33
+22.43%
0.27
Common Stock Issuance
0.00
0.00
-100.00%
213.18
0.00
Issuance Of Capital Stock
0.00
0.00
-100.00%
213.18
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category